Pakistan is set to launch its COVID-19 vaccination campaign this week as it received on Monday the first batch of a novel coronavirus vaccine developed by China.

Health Minister Faisal Sultan announced the news on Twitter saying, "the first batch of Sinopharm vaccine has arrived! Grateful to China and everyone who made this happen."

The minister received the vaccine consignment at the Nur Khan Airbase in the garrison city of Rawalpindi, neighboring Islamabad, where it arrived on board a Pakistan Air Force cargo plane.

Photo taken July 29, 2020, shows a cattle market on the outskirts of Islamabad, Pakistan. Many people bought sacrificial animals for the Muslim festival of Eid-ul-Adha online this year, so the market was less busy due to the coronavirus outbreak. (Kyodo) ==Kyodo

Chinese Foreign Minister Wang Yi had on Jan. 21 announced a gift of 500,000 doses of the vaccine produced by the state-owned China National Pharmaceutical Group Corp., known as Sinopharm.

Pakistan plans to additionally procure another 1.1 million doses of the vaccine from China this month.

The government plans to vaccinate the health workers in the first stage. About 400,000 such workers have registered for vaccination.

"A comprehensive countrywide vaccine administration has been formulated. All necessary measures have been put in place for vaccine storage at Islamabad and its transportation to the provinces by road and by air," said a spokesman for National Command and Operation Center, which oversees the anti-COVID-19 measures.

COVAX, the global pooled procurement mechanism for coronavirus vaccines, has meanwhile indicated that it would provide 17 million doses of the vaccine jointly developed by the University of Oxford and AstraZeneca Plc. The first batch of 7 million doses is likely to reach Pakistan this month.

The Health Ministry, in a statement, said that with the availability of vaccine from multiple sources, it is confident to meet the plan for "large scale immunization" over the next few months.

Pakistan's drug regulator has so far approved AstraZeneca, Sinopharm and Russia's Sputnik V vaccines for emergency use in the country.